Nucleopath, Inc. v. Indiana State Department of Public Welfare

639 N.E.2d 656, 1994 Ind. App. LEXIS 1097, 1994 WL 460133
CourtIndiana Court of Appeals
DecidedAugust 25, 1994
DocketNo. 49A02-9312-CV-665
StatusPublished

This text of 639 N.E.2d 656 (Nucleopath, Inc. v. Indiana State Department of Public Welfare) is published on Counsel Stack Legal Research, covering Indiana Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nucleopath, Inc. v. Indiana State Department of Public Welfare, 639 N.E.2d 656, 1994 Ind. App. LEXIS 1097, 1994 WL 460133 (Ind. Ct. App. 1994).

Opinion

BAKER, Judge.

We decide today whether the appellee-respondent Indiana State Department of Public Welfare (Department) wrongfully denied Medicaid reimbursement for clinical laboratory services by appellant-petitioners Nu-cleopath, Inc. and Medical Diagnostics, P.C. (collectively Laboratories). The Laboratories attack the trial court's decision affirming the interpretation of the appellee-respondent State Board of Public Welfare2 (Board) of the federal and state Medicaid reimbursement laws and regulations.

FACTS

Nucleopath and its successor, Medical Diagnostics, are Indiana professional medical corporations. The Laboratories have contracts with St. Mary's Medical Center in Lake County to operate laboratories in two hospitals. The Laboratories agreed not to be compensated by St. Mary's for the Medicaid services the Laboratories performed at St. Mary's hospitals. Instead, the Laboratories have "provider agreements" with the Department, the state agency that administers Indiana's Medicaid Program, to be compensated for their services rendered to Medicaid recipients at the hospital-based laboratories. Medicaid reimbursements are governed by federal and state statutes and regulations.

The Laboratories submitted claims to the Department for reimbursement, which claims included bills for general administration, [658]*658quality control of the laboratories, teaching, and establishing lab methodologies for the technicians. Dr. Earl Mason, President of the Laboratories, identified these claims as part of the "professional component" of the clinical laboratory procedures.

On June 1, 1986, the Department began denying Medicaid reimbursement on the Laboratories' claims for the professional component services because they did not require the direct involvement of a physician. The Department maintained that professional component services not requiring a physician's services in hospital-based laboratories are reimbursed only to the hospital under Medicaid law. The Laboratories sought a hearing before an administrative law judge (ALJ) challenging the Department's denials. The stipulated value of the claims rejected from June 1986 through March 1991 was $774,755.30. The ALJ found in favor of the Laboratories; however, the Board did not accept the ALJ's findings but rather upheld the Department's denials of payment on May 28, 1991. The Board declared that the Department does not pay hospital-based laboratories for such professional component services. The Board issued an amended decision on July 2, 1991, adopting the Department's proposed findings of fact and conclusions of law.

The Laboratories filed for judicial review. On March 25, 1993, the trial court entered numerous findings of fact and conclusions of law, affirming the Board's decision3

DISCUSSION AND DECISION

Judicial review of an administrative decision is limited to whether the agency possessed jurisdiction over the subject matter, whether its decision was made pursuant to proper procedures, was based upon substantial evidence, was not arbitrary or capricious, and was not in violation of any constitutional, statutory, or legal principle. Indiana Dep't of Natural Resources v. United Refuse Co. (1993), Ind., 615 N.E.2d 100, 103. The Laboratories do not dispute the findings of fact, rather their arguments attack the Board's interpretation of the Medicaid laws.4

Medicare, created under Title XVIII of the Social Security Act, is funded and administered by the federal government. Medicare provides health insurance to the aged and disabled. On the other hand, Medicaid was established under Title XIX of the Social Security Act and is regulated by the states, although funded jointly by the states and the federal government. Medicaid is intended to provide medical assistance to those who cannot afford it. A state must present a state Medicaid plan for the Department of Health and Human Services' (DHHS) approval in order to obtain federal funding. See Indiana State Dep't of Pub. Welfare v. Lifelines of Indianapolis Ltd. Partnership, (1994), Ind. App., 637 N.E.2d 1349 (discussion on Medicaid Act).

The Department rejected the Laboratories' claims by applying Medicare standards in reimbursing hospital-based laboratories for Medicaid services. The Laboratories deny that the Department has any power to apply Medicare standards to Medicaid reimbursements. To the contrary, the Department asserts that its authority to do so arises from 42 C.F.R. § 447.252 and Attachment 4.19-A of Indiana's Medicaid State Plan.

Indiana law mandates that Medicaid payments be made in compliance with any reimbursement criteria specified under federal law or regulations. IND. CODE § 12-15 13-2(b) (1992) (formerly IND. CODE § 12-1-7-17.6). Located in the federal Medicaid [659]*659regulatory section, 42 C.F.R. § 447.252(c) provides: "If the ageney chooses to apply the cost limits established under Medicare (see § 413.30 of this chapter)5 on an individual provider basis, the plan must specify this requirement." Following 42 C.F.R. § 447.-252(c) and I.C. § 12-15-13-2(b), the Department enacted Attachment 4.19-A in its Medicaid State Plan, which has been approved by the Health Care Financing Administration (HCFA) of the DHHS. Attachment 4.19-A directs the Indiana Medicaid Program to reimburse hospitals for costs of services in accordance with Title XVIII [Medicare] reimbursement provisions. Attachment 4.19-A further adopts the upper limits of Medicaid reimbursements as determined under Medicare costs principles. The particular federal Medicare regulations applicable to hospital-based laboratories are set forth in 42 C.F.R. §§ 405.550 6 and 405.556,7 and allow Medicaid reimbursement for laboratory services that require a physician's performance.

The Laboratories contend that the federal Medicaid regulations provide authority for the states to apply only the Medicare cost limits set forth in 42 C.F.R. § 413.30, not the Medicare reimbursement provisions in 42 C.F.R. §§ 405.550 and 405.556. Although 42 C.E.R. § 447.252(c) requires a state Medicaid plan to expressly adopt the Medicare cost limits if the state's ageney intends to apply those cost limits, it does not prohibit a state Medicaid plan from adopting other portions of the Medicare provisions. Indiana specifically adopted in Attachment 4.19-A the Medicare cost limits and its reimbursement provisions. The Laboratories fail to present any authority that precludes a state from applying the Medicare reimbursement provisions to its Medicaid plan.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
639 N.E.2d 656, 1994 Ind. App. LEXIS 1097, 1994 WL 460133, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nucleopath-inc-v-indiana-state-department-of-public-welfare-indctapp-1994.